Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherap...
Year-end report, May-April 2020/21
Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...
Elekta appoints Johan Adebäck as Chief Financial Officer
STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...
Elekta establishes office in Egypt to meet growing need for precision radiation medicine
STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...
Elekta's ProKnow to help standardize radiotherapy for veterans
Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...
Elekta divests its stake in ViewRay
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction. The shares in ViewRay were purchase...
Elekta reports major milestones achieved in MR-guided radiotherapy
STOCKHOLM, Dec. 8, 2020 /PRNewswire/ -- During the European Society for Radiotherapy and Oncology (ESTRO) and American Society for Radiation Oncology (ASTRO) Annual Meetings, users of the Elekta Unity MR-Linac presented 69 abstracts recounting the past years' worth of clinical experience with thi...
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room
VEENENDAAL, The Netherlands, Nov. 19, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced Elekta Studio with its launch of the ImagingRing, an advanced interventional CT system that revolves around the patient and enables clinicians to conduct the entire brachytherapy workflow - including ap...
Elekta Files Patent Infringement Lawsuit Against ZAP Surgical Systems Inc.
SUNNYVALE, California, April 26, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST), a pioneer in development of precision radiation therapy, radiosurgery and clinical software for the treatment of cancer and neurological disorders, announced today it has filed a patent infringement lawsuit against ZAP Surg...
Elekta Hits Radiotherapy Milestone With 5,000th Linear Accelerator Manufactured
STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades[1-2], access to radiotherapy - a key treatment modality for up to 60 percent of cancer patients - is more critical than ever. Since the manufacture ...
St. Vincent's Health Australia Expanding MOSAIQ Medical Oncology EHR to Total of Six Departments
SYDNEY, April 24, 2018 /PRNewswire/ -- St. Vincent's Health Australia (SVHA)
will expand its use of Elekta'sMOSAIQ® Medical Oncology
